Elicio Therapeutics Inc.
ELTX | NASDAQ
$1.82
-$0.09 (-4.71%)
Sep 22, 2026, 12:07 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.09 | -1.20 | -1.20 | -0.65 | -0.30 | -3.05 |
PEG Ratio | 0.08 | 0.03 | 0.05 | 0.01 | 0 | -0.11 |
PS Ratio | n/a | n/a | n/a | n/a | 0.67 | 16.67 |
PB Ratio | 74.50 | -5.50 | 3.71 | 2.05 | 0.23 | -0.53 |
P/FCF Ratio | -3.30 | -1.68 | -1.29 | -0.80 | -0.77 | -2.09 |
P/OCF Ratio | -3.30 | -1.68 | -1.29 | -0.82 | -0.79 | -2.10 |
OCF/S Ratio | n/a | n/a | n/a | n/a | -84.55 | -794.72 |
Debt / Equity Ratio | 8.87 | -2.30 | 0.61 | 0.84 | 0.06 | -0.94 |
Quick Ratio | 2.38 | 1.80 | 1.68 | 1.56 | 8.08 | 0.38 |
Current Ratio | 2.38 | 1.80 | 1.68 | 1.56 | 8.08 | 0.38 |
Asset Turnover | n/a | n/a | n/a | n/a | 0.29 | 0.06 |
Interest Coverage | -33.29 | -98.87 | -33.75 | -6.60 | -44.85 | -6.25 |
Return on Equity | -2.42K% | 458.79% | -309.46% | -316.41% | -32.39% | 88.57% |
Return on Assets | -153.01% | -184.18% | -129.65% | -124.46% | -27.35% | -169.19% |
Return on Invested Capital | -201% | -256.24% | -195.32% | -143.94% | -45.62% | -270.18% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | 95.64% | 36.88% |
Net Profit Margin | n/a | n/a | n/a | n/a | -93.25% | -2.78K% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | -192.76% | -2.78K% |
Operating Profit Margin | n/a | n/a | n/a | n/a | -138.84% | -1.92K% |
FCF Margin | n/a | n/a | n/a | n/a | -86.41% | -796.15% |
EBITDA Margin | n/a | n/a | n/a | n/a | -183.40% | -2.45K% |
Add to Watchlist
Select watchlists to add or remove ELTX